Trials / Completed
CompletedNCT02459457
A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer
A Comparison of Paclitaxel in Combination With Cisplatin(TP), Carboplatin(TC) or Fluorouracil(TF) Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Squamous Cell Carcinoma: A Three-Arm Randomized Phase III Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 321 (actual)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determined the best scheme in paclitaxel and cisplatin，paclitaxel and fluorouracil，paclitaxel and carboplatin concurrent with radiotherapy for patients with local advanced esophageal Squamous Cell Carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paclitaxel and Cisplatin | patients get Paclitaxel and Cisplatin according to protocol |
| DRUG | Paclitaxel and Fluorouracil | patients get Paclitaxel and Fluorouracil according to protocol |
| DRUG | Paclitaxel and Carboplatin | patients get Paclitaxel and Carboplatin according to protocol |
| RADIATION | Radiotherapy | 1.8Gy/d, d1-5/week, 34Fx |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2020-07-01
- Completion
- 2022-02-01
- First posted
- 2015-06-02
- Last updated
- 2022-02-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02459457. Inclusion in this directory is not an endorsement.